Manulife Finl Stock Price, News & Analysis

Manulife Investment Management has acquired the Joliet Logistics Center, a premier one million square foot logistics facility in Joliet, Illinois, located near Chicago. This state-of-the-art property, leased long-term to a major automobile manufacturer, enhances Manulife's portfolio in the Chicago region, known for its advantageous transportation infrastructure. The facility spans 60 acres and boasts modern features such as 36-foot clear heights and 226 dock doors. As of March 31, 2021, Manulife manages CAD $764.1 billion (USD $607.6 billion) in assets, underscoring its robust investment capabilities.

John Hancock Investment Management has launched the John Hancock Global Environmental Opportunities Fund, subadvised by Pictet Asset Management. This fund aims for capital appreciation by investing in companies that operate within the Planetary Boundaries framework, focusing on environmental sustainability. The fund targets sectors such as renewable energy, waste management, and pollution control, with Pictet bringing over 25 years of thematic investment expertise. The fund is timely as investors increasingly seek opportunities in environmentally conscious businesses.

Manulife Financial Corporation (MFC) is set to release its second quarter 2021 financial results after market close on August 4, 2021. A live webcast and conference call with executives will occur on August 5, 2021, at 8:00 a.m. (ET), discussing the results and followed by a Q&A session with analysts. Interested parties can access the conference via a toll-free number or through a dedicated link. Manulife serves over 30 million customers and manages approximately CAD$1.3 trillion in assets.

AM Best has affirmed an A+ (Superior) Financial Strength Rating and a long-term issuer credit rating of “aa-” (Superior) for the life/health subsidiaries of Manulife Financial Corporation (MFC), along with a stable outlook. MFC's strong balance sheet includes a Life Insurance Capital Adequacy Test (LICAT) ratio above peers and a solid pre-tax income exceeding CAD 5 billion over three years. However, concerns exist regarding the company's exposure to volatile legacy businesses and an elevated alternative investment portfolio, which may introduce earnings volatility.

John Hancock, a division of Manulife (NYSE: MFC), has launched its 14th annual MLK Scholars Program, the largest corporate summer jobs initiative in the U.S. Designed to provide summer employment and financial education, the program aims to prepare over 600 Boston youth for their financial futures. A recent study revealed that 77% of participants felt more confident in managing their finances post-program. The initiative, funded by $1.2 million, collaborates with local organizations and includes virtual personal development workshops.

On June 29, 2021, Manulife Financial Corporation hosted its Investor Day, focusing on strategies for growth in Asia and Global Wealth and Asset Management. Key presentations highlighted achieving significant targets ahead of schedule, including $5.9 billion in capital release and $1 billion in expense savings. Manulife aims to generate 75% of core earnings from its highest potential businesses by 2025. The company is committed to customer-centricity and enhanced digital capabilities, having invested over $750 million since 2018. Future goals include maintaining 10-12% annual Core EPS growth.

Manulife Investment Management announced the acquisition of TriVista on Speer, a luxury multifamily property in Denver, Colorado, for $144.5 million. This seven-story building features 322 units with large floorplans and high-end amenities, catering to young professionals. Strategically located in the Golden Triangle neighborhood, it is over 90% occupied and provides easy access to numerous employment opportunities. The acquisition aligns with Manulife's goal to expand its real estate portfolio in economically vibrant regions.

Manulife warns investors about an unsolicited mini-tender offer from Obatan LLC to buy up to 500,000 common shares at USD$12.00 each, representing a discount of approximately 38% from recent market prices. The offer is below market value, prompting concerns as mini-tender offers can mislead shareholders. Manulife advises investors to review the offer carefully and consult with their advisors. The company is not affiliated with Obatan and does not endorse the offer.